Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Porcine Netrin 1 ELISA Kit (AC3212)
Cat.#: ASET-1801
Specifications
Description Porcine Netrin 1 ELISA Kit allows for the in vitro quantitative determination of porcine Netrin 1 concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Porcine Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 37.5 pg/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 62.5-4000 pg/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1164 Human SATB2 ELISA Kit (AC2575) Quantitative inquiry ASET-1120 Mouse Renalase ELISA Kit (AC2531) Quantitative inquiry ASET-1361 Sheep Inhibin beta B ELISA Kit (AC2772) Quantitative inquiry ASET-2079 Mouse EGR2 ELISA Kit (AC3490) Quantitative inquiry ASET-2541 Human CD133 ELISA Kit (AC3952) Quantitative inquiry ASET-2011 Human Kappa Opioid Receptor ELISA Kit (AC3422) Quantitative inquiry ASET-1962 Mouse Renalase ELISA Kit (AC3373) Quantitative inquiry ASET-2410 Human NDRG1 ELISA Kit (AC3821) Quantitative inquiry ASET-1661 Mouse c-Kit ELISA Kit (AC3072) Quantitative inquiry ASET-1072 Human THIK-1 ELISA Kit (AC2483) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket